P-008: Single center, real-world, retrospective assessment of outcomes with idecabtagene vicleucel (ide-cel) for relapsed/refractory myeloma after prior treatment with a BCMA-targeted therapy

Authors :: Christopher Ferreri
Nilesh Kalariya
Misha Hawkins
Christen Dillard
Pei Lin
Elisabet Manasanch
Hans Lee
Robert Orlowski
Chitra Hosing
Muzaffar Qazilbash
Krina Patel
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S40-S41
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools